0 results found with selected filters. Please refine the filters. Redirecting to initial search..
Table "column sort" updates the order of the bars in the chart.
downloaded on: 2023/03/22 18:31:49
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Formula |
Value |
Units |
SEM |
SD |
Individual Records |
Method |
Method Duration |
Post Insult Time Value |
Experiment Notes |
Record ID |
Study ID |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
53.91 |
% |
5.6 |
15.83 |
M125FHBN15: 35.472
M117FHBN15: 38.407
M119FHBN15: 45.235
M114FHBN15: 46.64
M113FHBN15: 50.0
M110FHBN15: 65.237
M124FHBN15: 74.206
M120FHBN15: 76.055
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46094 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
57.81 |
% |
17.38 |
45.99 |
F112FHBN15: 25.773
F127FHBN15: 35.733
F116FHBN15: 39.196
F115FHBN15: 39.506
F121FHBN15: 50.0
F126FHBN15: 54.528
F122FHBN15: 159.911
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
46105 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49 days-63 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
48.53 |
% |
8.18 |
20.03 |
F105FHBN15: 29.594
F097FHBN15: 37.843
F096FHBN15: 42.81
F098FHBN15: 43.954
F095FHBN15: 50.0
F104FHBN15: 86.96
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47116 |
461 |
FHH-Chr 15BN/Mcwi |
percent change in arterial blood flow rate |
air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49 days-63 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
45.08 |
% |
2.81 |
7.96 |
M102FHBN15: 33.965
M093FHBN15: 38.095
M101FHBN15: 38.333
M103FHBN15: 43.2
M092FHBN15: 48.5
M091FHBN15: 50.0
M108FHBN15: 51.439
M090FHBN15: 57.137
|
isolated perfused heart effluent collection |
|
0 |
Moms and pups used in studies were fed Teklad |
47105 |
461 |
|